HELX holdings
Franklin Genomic Advancements ETF
Positions
63 stored of 63 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GUARDANT HEALTH INC GUARDANT HEALTH INC COM | US40131M1099 | 40131M109 | 9.090% | $2.5M | Equity (common) | Corporate | United States | USD |
| 2 | NATERA INC NATERA INC COM | US6323071042 | 632307104 | 7.461% | $2.1M | Equity (common) | Corporate | United States | USD |
| 3 | KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC COM | US5011471027 | 501147102 | 6.329% | $1.8M | Equity (common) | Corporate | United States | USD |
| 4 | LIGAND PHARMACEUTICALS INC LIGAND PHARMACEUTICALS INC COM NEW | US53220K5048 | 53220K504 | 4.622% | $1.3M | Equity (common) | Corporate | United States | USD |
| 5 | ADAPTIVE BIOTECHNOLOGIES CORP ADAPTIVE BIOTECHNOLOGIES CORP COM | US00650F1093 | 00650F109 | 3.989% | $1.1M | Equity (common) | Corporate | United States | USD |
| 6 | UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP COM | US91307C1027 | 91307C102 | 3.509% | $980K | Equity (common) | Corporate | United States | USD |
| 7 | BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC COM | US10806X1028 | 10806X102 | 3.500% | $978K | Equity (common) | Corporate | United States | USD |
| 8 | ELI LILLY & COMPANY ELI LILLY & COMPANY COM | US5324571083 | 532457108 | 2.954% | $825K | Equity (common) | Corporate | United States | USD |
| 9 | TWIST BIOSCIENCE CORP TWIST BIOSCIENCE CORP COM | US90184D1000 | 90184D100 | 2.849% | $796K | Equity (common) | Corporate | United States | USD |
| 10 | VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC COM | US92532F1003 | 92532F100 | 2.747% | $767K | Equity (common) | Corporate | United States | USD |
| 11 | ASTRAZENECA PLC ASTRAZENECA PLC ORD USD0.25 | GB0009895292 | Not reported | 2.701% | $754K | Equity (common) | Corporate | United Kingdom | USD |
| 12 | TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC COM | US89422G1076 | 89422G107 | 2.593% | $724K | Equity (common) | Corporate | United States | USD |
| 13 | INSMED INC INSMED INC COM PAR $.01 | US4576693075 | 457669307 | 2.438% | $681K | Equity (common) | Corporate | United States | USD |
| 14 | SAMSUNG BIOLOGICS CO LTD SAMSUNG BIOLOGICS CO LTD KRW2500 | KR7207940008 | Not reported | 2.256% | $630K | Equity (common) | Corporate | South Korea | KRW |
| 15 | CORTEVA INC CORTEVA INC COM | US22052L1044 | 22052L104 | 2.254% | $630K | Equity (common) | Corporate | United States | USD |
| 16 | MEDPACE HOLDINGS INC MEDPACE HOLDINGS INC COM | US58506Q1094 | 58506Q109 | 2.148% | $600K | Equity (common) | Corporate | United States | USD |
| 17 | ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS INC COM | US02043Q1076 | 02043Q107 | 1.957% | $547K | Equity (common) | Corporate | United States | USD |
| 18 | TEMPUS AI INC TEMPUS AI INC CL A | US88023B1035 | 88023B103 | 1.949% | $544K | Equity (common) | Corporate | United States | USD |
| 19 | IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC COM | US4622221004 | 462222100 | 1.913% | $534K | Equity (common) | Corporate | United States | USD |
| 20 | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM | US64125C1099 | 64125C109 | 1.845% | $515K | Equity (common) | Corporate | United States | USD |
| 21 | REGENERON PHARMACEUTICALS INC REGENERON PHARMACEUTICALS INC COM | US75886F1075 | 75886F107 | 1.797% | $502K | Equity (common) | Corporate | United States | USD |
| 22 | VERACYTE INC VERACYTE INC COM | US92337F1075 | 92337F107 | 1.644% | $459K | Equity (common) | Corporate | United States | USD |
| 23 | ARGENX SE ARGENX SE EUR0.10 | NL0010832176 | Not reported | 1.640% | $458K | Equity (common) | Corporate | Netherlands | EUR |
| 24 | PTC THERAPEUTICS INC PTC THERAPEUTICS INC COM | US69366J2006 | 69366J200 | 1.463% | $409K | Equity (common) | Corporate | United States | USD |
| 25 | BIONTECH SE BIONTECH SE SPONSORED ADS | US09075V1026 | 09075V102 | 1.384% | $387K | Equity (common) | Corporate | Germany | USD |
| 26 | STOKE THERAPEUTICS INC STOKE THERAPEUTICS INC COM | US86150R1077 | 86150R107 | 1.329% | $371K | Equity (common) | Corporate | United States | USD |
| 27 | CHARLES RIVER LABORATORIES INTERNATIONAL INC CHARLES RIVER LABORATORIES INTERNATIONAL INC COM | US1598641074 | 159864107 | 1.263% | $353K | Equity (common) | Corporate | United States | USD |
| 28 | GRAIL INC GRAIL INC COM | US3847471014 | 384747101 | 1.089% | $304K | Equity (common) | Corporate | United States | USD |
| 29 | ANAPTYSBIO INC ANAPTYSBIO INC COM | US0327241065 | 032724106 | 1.037% | $290K | Equity (common) | Corporate | United States | USD |
| 30 | CRISPR THERAPEUTICS AG CRISPR THERAPEUTICS AG NAMEN AKT | CH0334081137 | Not reported | 0.982% | $274K | Equity (common) | Corporate | Switzerland | USD |
| 31 | REPLIGEN CORP REPLIGEN CORP COM | US7599161095 | 759916109 | 0.981% | $274K | Equity (common) | Corporate | United States | USD |
| 32 | CADENCE DESIGN SYSTEMS INC CADENCE DESIGN SYSTEMS INC COM | US1273871087 | 127387108 | 0.974% | $272K | Equity (common) | Corporate | United States | USD |
| 33 | BEAM THERAPEUTICS INC BEAM THERAPEUTICS INC COM | US07373V1052 | 07373V105 | 0.931% | $260K | Equity (common) | Corporate | United States | USD |
| 34 | PRAXIS PRECISION MEDICINES INC PRAXIS PRECISION MEDICINES INC COM NEW | US74006W2070 | 74006W207 | 0.860% | $240K | Equity (common) | Corporate | United States | USD |
| 35 | SARTORIUS AG SARTORIUS AG NON VTG PFD NPV | DE0007165631 | Not reported | 0.850% | $238K | Equity (preferred) | Corporate | Germany | EUR |
| 36 | AXSOME THERAPEUTICS INC AXSOME THERAPEUTICS INC COM | US05464T1043 | 05464T104 | 0.820% | $229K | Equity (common) | Corporate | United States | USD |
| 37 | CAREDX INC CAREDX INC COM | US14167L1035 | 14167L103 | 0.816% | $228K | Equity (common) | Corporate | United States | USD |
| 38 | JAZZ PHARMACEUTICALS PLC JAZZ PHARMACEUTICALS PLC SHS USD | IE00B4Q5ZN47 | Not reported | 0.781% | $218K | Equity (common) | Corporate | Ireland | USD |
| 39 | CATALYST PHARMACEUTICALS INC CATALYST PHARMACEUTICALS INC COM | US14888U1016 | 14888U101 | 0.772% | $216K | Equity (common) | Corporate | United States | USD |
| 40 | THERMO FISHER SCIENTIFIC INC THERMO FISHER SCIENTIFIC INC COM | US8835561023 | 883556102 | 0.756% | $211K | Equity (common) | Corporate | United States | USD |
| 41 | IQVIA HOLDINGS INC IQVIA HOLDINGS INC COM | US46266C1053 | 46266C105 | 0.748% | $209K | Equity (common) | Corporate | United States | USD |
| 42 | HINGE HEALTH INC HINGE HEALTH INC CL A | US4333131039 | 433313103 | 0.698% | $195K | Equity (common) | Corporate | United States | USD |
| 43 | ULTRAGENYX PHARMACEUTICAL INC ULTRAGENYX PHARMACEUTICAL INC COM | US90400D1081 | 90400D108 | 0.613% | $171K | Equity (common) | Corporate | United States | USD |
| 44 | AGILENT TECHNOLOGIES INC AGILENT TECHNOLOGIES INC COM | US00846U1016 | 00846U101 | 0.582% | $162K | Equity (common) | Corporate | United States | USD |
| 45 | DANAHER CORP DANAHER CORP COM | US2358511028 | 235851102 | 0.574% | $160K | Equity (common) | Corporate | United States | USD |
| 46 | QIAGEN NV QIAGEN NV ORD SHARES | NL0015002SN0 | Not reported | 0.479% | $134K | Equity (common) | Corporate | Netherlands | USD |
| 47 | RHYTHM PHARMACEUTICALS INC RHYTHM PHARMACEUTICALS INC COM | US76243J1051 | 76243J105 | 0.417% | $116K | Equity (common) | Corporate | United States | USD |
| 48 | ARCUTIS BIOTHERAPEUTICS INC ARCUTIS BIOTHERAPEUTICS INC COM | US03969K1088 | 03969K108 | 0.415% | $116K | Equity (common) | Corporate | United States | USD |
| 49 | SAMSUNG EPIS HOLDINGS CO LTD SAMSUNG EPIS HOLDINGS CO LTD KRW2500 | KR70126Z0002 | Not reported | 0.374% | $104K | Equity (common) | Corporate | South Korea | KRW |
| 50 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC KINIKSA PHARMACEUTICALS INTERNATIONAL PLC ORD SHS CL A | GB00BRXB0C07 | Not reported | 0.339% | $95K | Equity (common) | Corporate | United Kingdom | USD |
| 51 | TARSUS PHARMACEUTICALS INC TARSUS PHARMACEUTICALS INC COM | US87650L1035 | 87650L103 | 0.256% | $71K | Equity (common) | Corporate | United States | USD |
| 52 | BIO-RAD LABORATORIES INC BIO-RAD LABORATORIES INC CL A | US0905722072 | 090572207 | 0.255% | $71K | Equity (common) | Corporate | United States | USD |
| 53 | LIQUIDIA CORP LIQUIDIA CORP COM NEW | US53635D2027 | 53635D202 | 0.249% | $69K | Equity (common) | Corporate | United States | USD |
| 54 | BRISTOL-MYERS SQUIBB COMPANY BRISTOL-MYERS SQUIBB COMPANY COM | US1101221083 | 110122108 | 0.247% | $69K | Equity (common) | Corporate | United States | USD |
| 55 | TG THERAPEUTICS INC TG THERAPEUTICS INC COM | US88322Q1085 | 88322Q108 | 0.246% | $69K | Equity (common) | Corporate | United States | USD |
| 56 | BEONE MEDICINES LTD BEONE MEDICINES LTD SPONSORED ADS | US07725L1026 | 07725L102 | 0.230% | $64K | Equity (common) | Corporate | Switzerland | USD |
| 57 | NEUROGENE INC NEUROGENE INC COM | US64135M1053 | 64135M105 | 0.223% | $62K | Equity (common) | Corporate | United States | USD |
| 58 | FIRST TRACKS BIOTHERAPEUTICS INC FIRST TRACKS BIOTHERAPEUTICS INC ORD SHS | US3371851029 | 337185102 | 0.200% | $56K | Equity (common) | Corporate | United States | USD |
| 59 | GENEDX HOLDINGS CORP GENEDX HOLDINGS CORP COM CL A | US81663L2007 | 81663L200 | 0.141% | $39K | Equity (common) | Corporate | United States | USD |
| 60 | WAVE LIFE SCIENCES LTD WAVE LIFE SCIENCES LTD SHS | SG9999014716 | Not reported | 0.100% | $28K | Equity (common) | Corporate | Singapore | USD |
| 61 | RECURSION PHARMACEUTICALS INC RECURSION PHARMACEUTICALS INC CL A | US75629V1044 | 75629V104 | 0.072% | $20K | Equity (common) | Corporate | United States | USD |
| 62 | OMNIAB INC OMNIAB INC USD0.0001 A (USD12.5 VESTING) | US68218J2024 | 68218J202 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 63 | OMNIAB INC OMNIAB INC USD0.0001 A (USD15 VESTING) | US68218J3014 | 68218J301 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |